Moreover, VDAC1 could interact with many proteins, such as metabolism, apoptosis and anti-oxidation-related proteins [102,103], so it could be regarded as a potential therapeutic for metabolic liver disease, such as NAFLD [98]. The gene discussed is VDAC1; the disease is metabolic dysfunction-associated steatotic liver disease.